- Home
- Applications
- switzerland
- drug development
Show results for
Refine by
Drug Development Product Applications In Switzerland
7 applications found
DART enables near effortless inspection of tablets, powder, and liquid formulations. Qualitative and quantitative analysis are completed by using commercially available LC/MS systems from all of the major mass spectrometry vendors. Rapid reaction monitoring is facilitated with the development of our Mobile DART-Acquity QDa platform which can move from laboratory to pilot plant in minutes enabling generation of high quality information in seconds to improve your decision making process. ...
ByBruker Corporation based in Billerica, MASSACHUSETTS (USA)
Realize the value of global clinical and genomic data with us. We help reduce your risk, enhance your pipeline value and advance your enterprise data strategy by solving the barriers of data access and enabling rapid insight ...
ByBC Platforms based in Zürich, SWITZERLAND
Facilitate the construction of human skin equivalents for wound healing research, cosmetic product development or drug delivery ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Our 3D printers are designed to develop research into complex drug formulation and delivery challenges. ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Introducing single-cell biopsy The novel non-invasive method for single-cell omics The novel method that keeps your cells alive during biopsy from single cells Single-cell omics addresses cellular heterogeneity head on by isolating and analyzing molecular components from individual cells. While many of the existing technologies rely on cell lysis — single-cell biopsy is the only non-invasive single-cell analysis method that allows researchers to take transcriptome snapshots of a ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
FluidFM can therefore help to illuminate fundamental questions on virulence, virus replication, or host immune response and thereby boost the development of novel antiviral drugs and vaccines. ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)